-
Signature
-
/s/ Brian Grube, Attorney-in-Fact
-
Issuer symbol
-
INTA
-
Transactions as of
-
12 Jun 2023
-
Net transactions value
-
-$539,252
-
Form type
-
4
-
Filing time
-
14 Jun 2023, 17:29:41 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
INTA |
Common Stock |
Options Exercise |
$11,866 |
+2,974 |
+0.54% |
$3.99* |
558,384 |
12 Jun 2023 |
Direct |
F1 |
| transaction |
INTA |
Common Stock |
Sale |
$145,746 |
-2,974 |
-0.53% |
$49.01 |
555,410 |
12 Jun 2023 |
Direct |
F1, F2, F3 |
| transaction |
INTA |
Common Stock |
Options Exercise |
$35,930 |
+9,005 |
+1.6% |
$3.99* |
564,415 |
13 Jun 2023 |
Direct |
F1 |
| transaction |
INTA |
Common Stock |
Sale |
$441,303 |
-9,005 |
-1.6% |
$49.01 |
555,410 |
13 Jun 2023 |
Direct |
F1, F3, F4 |
| holding |
INTA |
Common Stock |
|
|
|
|
|
150,000 |
12 Jun 2023 |
By Gambatte LLC |
F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
INTA |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-2,974 |
-0.61% |
$0.000000 |
482,626 |
12 Jun 2023 |
Common Stock |
2,974 |
$3.99 |
Direct |
F1, F6 |
| transaction |
INTA |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-9,005 |
-1.9% |
$0.000000 |
473,621 |
13 Jun 2023 |
Common Stock |
9,005 |
$3.99 |
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: